BioSig Technologies, Inc. (BSGM) Just Recorded A Sigfniciant Increase

BioSig Technologies, Inc. (NASDAQ:BSGM) Logo

The stock of BioSig Technologies, Inc. (NASDAQ:BSGM) is a huge mover today! The stock increased 3.56% or $0.3 during the last trading session, reaching $8.74. About 195,774 shares traded or 65.93% up from the average. BioSig Technologies, Inc. (NASDAQ:BSGM) has risen 61.18% since May 15, 2018 and is uptrending. It has outperformed by 56.81% the S&P500.
The move comes after 9 months positive chart setup for the $178.26 million company. It was reported on May, 15 by Barchart.com. We have $9.26 PT which if reached, will make NASDAQ:BSGM worth $10.70M more.

More notable recent BioSig Technologies, Inc. (NASDAQ:BSGM) news were published by: Globenewswire.com which released: “Frank J. Quintero Joins BioSig Technologies Advisory Board – GlobeNewswire” on April 09, 2019, also Time.com with their article: “JK Rowling Confirms Hermione Theory Once and for All – TIME” published on September 18, 2018, Prnewswire.com published: “US Remains Largest Medical Device Market Estimated at Over $150 Billion – PRNewswire” on May 06, 2019. More interesting news about BioSig Technologies, Inc. (NASDAQ:BSGM) were released by: Time.com and their article: “Nathan W. Pyle’s Strange Planet Is Comic Relief for the Instagram Age – TIME” published on March 15, 2019 as well as Time.com‘s news article titled: “Virginia Sets Up First Historical Marker for Lynching Victim – TIME” with publication date: April 09, 2019.

BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. The company has market cap of $178.26 million. The Company’s product is PURE EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures. It currently has negative earnings. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.